期刊文献+

心肾综合征研究进展 被引量:8

Advances on research of cardiorenal syndrome
下载PDF
导出
摘要 心肾综合征是指心脏或肾脏急性或慢性功能障碍而导致另一器官的急性或慢性功能损害的临床综合征.根据心肾疾病发病的相互关系将其分为五型.目前认为发病机制与肾素-血管紧张素-醛固酮系统及交感神经系统的过度激活、一氧化氮/氧自由基的失衡、贫血、炎症等相关.心肾综合征的治疗方面尚缺乏大样本临床试验资料,可选择利尿剂、血管紧张素转化酶抑制剂/血管紧张素受体拮抗剂、β-受体阻滞剂、促红细胞生成素等,一些新型药物如选择性腺苷A1受体拮抗剂、血管加压素受体拮抗剂正进入临床,如出现药物抵抗应早期行肾脏替代治疗. The cardiorenal syndrome (CRS) is defined as a complex pathophysiological disorder of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other. A new classification of CRS has been proposed with five subtypes that reflect the pathophysiology, the bidirectional nature of heart and kidney interaction and the time-frame. The pathophysiology of the CRS involves interrelated hemodynamic and neurohormonal mechanisms, including the renin-angiotensin- aldosterone system, the sympathetic nervous system, the imbalance between nitric oxide and reactive oxygen species, anemia, inflammation and others such as endothelin and arginine vasopressin system activation. CRS remains a challenge in treatment options. Traditional agents, including diuretics, angiotensin converting enzyme inhibitors/angiotensin receptor blocker, 13-blockers and erythropoietin, are chosen to alleviate symptoms. Novel agents, such as adenosine A1 antagonists and vasopressin receptor antagonists, have been evaluated in randomized controlled trials. Renal replacement therapy should be used early if diuretic resistance exists.
出处 《中华老年多器官疾病杂志》 2012年第1期6-10,共5页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 心肾综合征 发病机制 分类 治疗 cardiorenal syndrome pathogenesis classification treatment
  • 相关文献

参考文献20

  • 1Smith GL,Lichtman JH,BrackenMB,et al.Renal impairment and outcomes in heart failure:systematic review and meta-analysis[J].J Am Coll Cardiol,2006,47 (10):1987-1996.
  • 2Ronco C,Happio M,Mouse AA,et al.Cardiorenal syndrome[J].J Am Coll Cardiol,2008,52(19):1527-1539.
  • 3Ronco C,McCullough P,et al.Cardiorenal syndrome:report from the consensus conference of the Acute Dialysis Quality Initiative[J].Eur Heart J,2010,31(6):703-711.
  • 4Ronco C,House AA,Haapio M.Cardiorenal syndrome:refining the definition of a complex symbiosis gone wrong[J].Intensive Care Med,2008,34(5):957-962.
  • 5Brewster UC,Setaro JF,Perazella MA.The renin-angiotensin-aldosterone system:cardiorenal effects and implications for renal and cardiovascular disease states[J].Am J Med Sci,2003,326(1):15-24.
  • 6Bongartz LG,Cramer MJ,Doevendans PA,et al.The severe cardiorenal syndrome:Guyton revisited[J].Eur Heart J,2005,26(1):11-17.
  • 7Wassmann S,Stumpf M,Strehlow K,et al.Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin Ⅱ type 1 receptor[J].Circ Res,2004,94(4):534-541.
  • 8Heart Failure Society of America.HFSA 2006 comprehensive heart failure guideline[J].J Card Fail,2006,12(1):1-2.
  • 9Felker GM,Lee KL,Bull DA,et al.Diuretic strategies in patients with acute decompensated heart failure[J].N Engl J Med,2011,3; 364(9):797-805.
  • 10Dittrich HC,Gupta DK,Hack TC,et al.The effect of KW-3902,an adensine A1 receptor antagonist,on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment[J].J Card Fail,2007,13(8):609-617.

同被引文献59

  • 1严静.成人严重感染与感染性休克血流动力学监测与支持指南(2006)[J].中国实用外科杂志,2007,27(1):7-13. 被引量:132
  • 2陆再英,钟南山.内科学[M].7版:北京人民出版社,2010:770-793.
  • 3王海燕.肾脏病学[M].北京:人民卫生出版社,2001.891.
  • 4Ronco C,Haapio M5 House AAs et al.Cardiorenalsyndrome[J].J Am Coll Cardiol,2008,52(19):1527-1539.
  • 5Ronco C,Chionh CY,Haapio M,et al.The cardiorenalsyndrome[J].Blood Purif,2009,27(1):114-126.
  • 6Smith GL,Shlipak MG,Havranek EP,et al.Race andrenal impairment in heart failure,mortality in blacksversus whitestJ].Circulation,2005,111(10):1270-1277.
  • 7Hunt SA,Abraham WT,Chin MH,et al ACC/AHA 2005Guideline Update for the Diagnosis and Management ofChronic Heart Failure in the Adult:a report of theAmerican College of Cardiology/American HeartAssociation Task Force on Practice Guidelines(WritingCommittee to Update the 2001 Guidelines for theEvaluation and Management of Heart Failure):developedin collaboration with the American College of ChestPhysicians and the International Society for Heart andLung Transplantation; endorsed by the Heart RhythmSociety[J].Circulation,2005,112(12):el54-e235.
  • 8Weeks SG.Nesiritide:the clinical experience[J].Can JCardiol,2008,24:19B-21B.
  • 9Spinarova L5 Vitover J.Neurohumoral changes in chronicheart failure[J].Biomed Pap Med Fac Univ PalackyOlomouc Czech Repub,2007,151(2):201-207.
  • 10Owan TE,Chen HH,Frantz RP,et al.The effects ofnesitritide on renal function and diuretic responsivenessin acutely decompensated heart failure patients with renaldysfunction[J],J Cardiac Fail,2008,14(4):267-275.

引证文献8

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部